AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells
Keyword(s):
2014 ◽
Vol 113
(3)
◽
pp. 141-142
◽
Keyword(s):
2018 ◽
Vol 17
(2)
◽
pp. 499-507
◽
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 9
(6)
◽
pp. 2417-2422
◽
Keyword(s):
2019 ◽
Keyword(s):
Keyword(s):